Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
A dual-pronged host-directed therapeutic targeting cyclophilin A and pathogenic interferon response abrogates virus-triggered pregnancy pathologies
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 29 May 2026

A dual-pronged host-directed therapeutic targeting cyclophilin A and pathogenic interferon response abrogates virus-triggered pregnancy pathologies

  • Wenzhe Yu1,2 na1,
  • Hongmin Cao2 na1,
  • Zhifang Deng2 na1,
  • Jiahao Chen3,
  • Beiang Zhang3,
  • Shuai Zhu4,
  • Dunjin Chen  ORCID: orcid.org/0000-0002-1839-34691,
  • Xiaoqian Hu  ORCID: orcid.org/0000-0002-6975-40683 &
  • …
  • Bin Cao  ORCID: orcid.org/0000-0003-2516-790X2 

Nature Communications (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Antiviral agents
  • Innate immunity
  • Viral infection
  • Virus–host interactions

Abstract

Pathogenic viruses threaten fetal development by achieving vertical transmission and instigating placental immunopathology, while the pathobiological mechanisms and effective therapeutics remain critical gaps. Here, we reveal cyclophilin A (CypA) as a crucial host factor necessary for Zika virus (ZIKV) replication in human placental trophoblasts, acting independently of its canonical functions. ZIKV infection recruits CypA into the viral replication organelle and reconfigures its interactome, thereby subverting host RNA decay machinery and stress granule-mediated antiviral surveillance. Both genetic ablation of CypA and its pharmacological inhibition with clinically approved drug ciclosporin A (CsA) restrict ZIKV transplacental transmission and corresponding placental and fetal pathologies. Beyond its anti-ZIKV potency, CsA concurrently counteracts pathological type I interferon signaling by targeting the JAK1-STAT1/2 pathway, broadly ameliorating pregnancy-specific interferonopathies driven by viral infection or endogenous double-stranded RNA stress. Our findings elucidate CypA-governed ZIKV pathogenesis and license CsA as a promising dual-action therapeutic to counteract congenital viral infections.

Acknowledgements

We thank Drs. Jiahuai Han and Haibin Wang at Xiamen University for providing genetic mouse models.

Funding

This work was supported by grants from the National Natural Sciences Foundation in China (82130047 to B.C., 82401973 to W.Y., and 82571928 to X.H.), the National Key Research and Development Program of China (2022YFC2702400 to B.C. and 2022YFC2704702 to X.H.), Natural Science Foundation of Xiamen, China (3502Z202372001 to X.H.), Open Funding of State Key Laboratory of Reproductive Medicine and offspring health (SKLRM-K202401 to B.C.), Fundamental Research Funds for the Central Universities (20720240113 to X.H.).

Author information

Author notes
  1. These authors contributed equally: Wenzhe Yu, Hongmin Cao, Zhifang Deng.

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

    Wenzhe Yu & Dunjin Chen

  2. Fujian Provincial Key Laboratory of Reproductive Health Research, Department of Obstetrics and Gynecology, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China

    Wenzhe Yu, Hongmin Cao, Zhifang Deng & Bin Cao

  3. State Key Laboratory of Vaccine for Infectious Disease, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China

    Jiahao Chen, Beiang Zhang & Xiaoqian Hu

  4. State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China

    Shuai Zhu

Authors
  1. Wenzhe Yu
    View author publications

    Search author on:PubMed Google Scholar

  2. Hongmin Cao
    View author publications

    Search author on:PubMed Google Scholar

  3. Zhifang Deng
    View author publications

    Search author on:PubMed Google Scholar

  4. Jiahao Chen
    View author publications

    Search author on:PubMed Google Scholar

  5. Beiang Zhang
    View author publications

    Search author on:PubMed Google Scholar

  6. Shuai Zhu
    View author publications

    Search author on:PubMed Google Scholar

  7. Dunjin Chen
    View author publications

    Search author on:PubMed Google Scholar

  8. Xiaoqian Hu
    View author publications

    Search author on:PubMed Google Scholar

  9. Bin Cao
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Dunjin Chen, Xiaoqian Hu or Bin Cao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Peer Review file (download PDF )

Reporting Summary (download PDF )

Source data

Source Data (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, W., Cao, H., Deng, Z. et al. A dual-pronged host-directed therapeutic targeting cyclophilin A and pathogenic interferon response abrogates virus-triggered pregnancy pathologies. Nat Commun (2026). https://doi.org/10.1038/s41467-026-73497-z

Download citation

  • Received: 22 November 2025

  • Accepted: 13 May 2026

  • Published: 29 May 2026

  • DOI: https://doi.org/10.1038/s41467-026-73497-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing